Tag: valbenazine

Zydus Lifesciences gets FDA tentative approval for Valbenazine Capsules

businessnewstoday- October 17, 2022

Zydus Lifesciences (previously called Cadila Healthcare) said that its subsidiary Zydus Worldwide DMCC has been given tentative approval from the US Food and Drug Administration ... Read More

Neurocrine’s Ingrezza approved by FDA for tardive dyskinesia treatment

pharmanewsdaily- April 15, 2017

The US Food and Drug Administration (FDA) has approved for Ingrezza (valbenazine) capsules developed by Neurocrine Biosciences for the treatment of tardive dyskinesia patients. A ... Read More